Acute Coronary Syndrome

Overview


In this module, we'll go over acute coronary syndrome (ACS), which describes many clinical symptoms caused by acute myocardial ischemia. ACS includes unstable angina, NSTEMI (non ST-elevated myocardial infarction), and STEMI (ST-elevated myocardial infarction).

Unstable Angina
Stable Angina
Vasospastic Angina
NSTEMI
STEMI
Clinical Presentation

Pain with exertion or at rest

Pain with exertion

Transient discomfort at rest usually at night

Pain at rest

Pain at rest

Troponin Levels

Normal

Normal

Normal

Increased

Increased

ECG Changes

Can have ST depressions or T-wave inversions

Can have ST depression

Transient ST elevation

ST depression

ST elevation

Infarction

None

None

None

Subendocardial infarction

Transmural infarction

Treatment

Anti-platelet and anticoagulants

Nitroglycerin

Calcium channel blockers

Anti-platelet + ADP receptor antagonist, anticoagulants

Reperfusion therapy

Unstable (Atypical) Angina


Cause: atherosclerotic plaque rupture, thrombosis with incomplete coronary artery occlusion

Clinical Presentation: new-onset, unprovoked, discomfort with stress or rest, lasts 20-30 minutes, not relieved by rest or anti-anginal medication (nitroglycerin)


ECG Changes: ST depression or T-wave inversions on ECG and normal troponin; send patient to cath lab if patient has high risk score (TIMI, GRACE), poor symptoms, or arrhythmia


Treatment: anti-platelet drugs and anticoagulants; symptom control with nitroglycerin (make sure patient is not on phosphodiesterase inhibitor such as Viagra before prescribing nitroglycerin to prevent severe vasodilation) +/- morphine; can also include B-blockers, ACE inhibitors, and statins

Aspirin
Clopidogrel
Heparin
Type of Drug

Anti-platelet

Anti-platelet

Anticoagulation

Mechanism of Action

COX1 inhibitor

ADP receptor antagonist

Factor Xa inhibitor

How do stable angina and variant (Prinzmetal) angina compare to unstable angina?

Although stable and variant angina are not part of ACS, it is appropriate to discuss them here to differentiate them from unstable angina.


Stable Angina

Cause: fixed atherosclerotic narrowing

Clinical Presentation: heavy substernal discomfort, initiated by increased physical activity/stress/exertion, lasts 5 minutes or less, and relieved by rest or anti-anginal medication (nitroglycerin)

ECG Changes: ST-segment depression possible

Treatment: nitroglycerin, B-blockers


Vasospastic (Prinzmetal/Variant) Angina

Cause: coronary artery vasospasm triggered by cocaine, alcohol, or triptans; smoking tobacco is a risk factor

Clinical Presentation: discomfort at rest without stress, transient, occurs at night

ECG Changes: transient ST-segment elevation

Treatment: calcium channel blockers, nitrates, smoking cessation

NSTEMI


Cause: partial coronary artery obstruction; coagulative necrosis of myocardium due to acute, severe ischemia (disrupted blood flow)


ECG Changes: ST depression on ECG but increased troponin; send patient to cath lab if patient has high risk score (TIMI, GRACE), poor symptoms, or arrhythmia


Treatment: anti-platelet drugs + ADP receptor antagonists, anticoagulants, B-blockers, ACE inhibitors, statins; symptom control with nitroglycerin (make sure patient is not on phosphodiesterase inhibitor such as Viagra before prescribing nitroglycerin to prevent severe vasodilation) +/- morphine

STEMI


Cause: complete coronary artery obstruction; coagulative necrosis of myocardium due to acute, severe ischemia (disrupted blood flow)


ECG Changes: ST elevation on ECG and increased troponin; send patient to cath lab immediately


Treatment:

  1. anti-platelet drugs + ADP receptor antagonists, anticoagulants, B-blockers, ACE inhibitors, statins; symptom control with nitroglycerin (make sure patient is not on phosphodiesterase inhibitor such as Viagra before prescribing nitroglycerin to prevent severe vasodilation) +/- morphine
  2. reperfusion therapy (percutaneous coronary intervention rather than fibrinolysis); if there is occlusion of right coronary artery, it is important to maintain cardiac output by providing IV fluids and avoiding nitroglycerin